Kristhel Gaitán-Zambrano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristhel Gaitán-Zambrano has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- César Alas-Pineda
Quantitative Biomedical Sciences Doctoral Program, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA
13 shared publications - Dennis J. Pavón-Varela
Department of Research and Development, Moxie Health Group, Hallandale Beach, FL 33009, USA
5 shared publications - Gustavo Ferrer
Department of Pulmonary and Critical Care Medicine, Aventura Hospital and Medical Center, Aventura, FL 33180, USA
5 shared publications - Carlos Coto-Tejeda
Department of Research and Development, Moxie Health Group, Hallandale Beach, FL 33009, USA
3 shared publications - Jhacely Medina-Mejía
Department of Research and Development, Moxie Health Group, Hallandale Beach, FL 33009, USA
3 shared publications - Suyapa Bejarano
Universidad Católica de Honduras "Nuestra Señora Reina de la Paz", Tegucigalpa, Honduras.
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3598
Pregnancy-Recognized Obstructive Sleep Apnea and Maternal–Fetal Outcomes: A Narrative Review of Gestational Rhinitis, Upper-Airway Mechanisms, and Treatment Evidence
Background/Objectives: Pregnancy-recognized obstructive sleep apnea (POSA) is an operational construct, not a validated biological phenotype, and remains underrecognized in prenatal care. This review synthesizes evidence on POSA-related outcomes, evaluates gestational rhinitis as a candidate contributor to upper-airway vulnerability, and distinguishes pregnancy safety from demonstrated efficacy for OSA-related endpoints. Methods: This structured narrative review, informed by SANRA criteria, used a structured PubMed search (7 March 2026) with targeted supplementary searches through 9 October 2026, across six predefined domains. Results: Pregnancy-recognized OSA is associated in observational studies with hypertensive disorders, preterm birth, impaired fetal growth (in small pregnancy-specific studies), and severe maternal morbidity; residual confounding by obesity precludes causal inference. In a 2024 meta-analysis of randomized and observational studies (n = 809), continuous positive airway pressure (CPAP) was associated with lower risks of gestational hypertension (RR, 0.65; 95% CI, 0.47–0.89) and preeclampsia (RR, 0.70; 95% CI, 0.50–0.98). Although secondary endpoints in individual trials suggested benefit, the pooled preeclampsia effect was fragile in sensitivity and subgroup analyses. Gestational rhinitis affects approximately one in five pregnant women and is a plausible but untested contributor to pregnancy-recognized OSA. Saline irrigation, budesonide (mainly inhaled-exposure data), and chlorpheniramine have gestational safety data, but the only randomized trial of an intranasal corticosteroid in gestational rhinitis was null, and we identified no study of OSA endpoints. Conclusions: Given the largely observational evidence, objective testing and individualized treatment may be considered in high-risk patients, pending adequately powered trials. CPAP is the standard treatment for objectively confirmed OSA.
- 23 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3598
Open AccessPregnancy-Recognized Obstructive Sleep Apnea and Maternal–Fetal Outcomes: A Narrative Review of Gestational Rhinitis, Upper-Airway Mechanisms, and Treatment Evidence
Background/Objectives: Pregnancy-recognized obstructive sleep apnea (POSA) is an operational construct, not a validated biological phenotype, and remains underrecognized in prenatal care. This review synthesizes evidence on POSA-related outcomes, evaluates gestational rhinitis as a candidate contributor to upper-airway vulnerability, and distinguishes pregnancy safety from demonstrated efficacy for OSA-related endpoints. Methods: This structured narrative review, informed by SANRA criteria, used a structured PubMed search (7 March 2026) with targeted supplementary searches through 9 October 2026, across six predefined domains. Results: Pregnancy-recognized OSA is associated in observational studies with hypertensive disorders, preterm birth, impaired fetal growth (in small pregnancy-specific studies), and severe maternal morbidity; residual confounding by obesity precludes causal inference. In a 2024 meta-analysis of randomized and observational studies (n = 809), continuous positive airway pressure (CPAP) was associated with lower risks of gestational hypertension (RR, 0.65; 95% CI, 0.47–0.89) and preeclampsia (RR, 0.70; 95% CI, 0.50–0.98). Although secondary endpoints in individual trials suggested benefit, the pooled preeclampsia effect was fragile in sensitivity and subgroup analyses. Gestational rhinitis affects approximately one in five pregnant women and is a plausible but untested contributor to pregnancy-recognized OSA. Saline irrigation, budesonide (mainly inhaled-exposure data), and chlorpheniramine have gestational safety data, but the only randomized trial of an intranasal corticosteroid in gestational rhinitis was null, and we identified no study of OSA endpoints. Conclusions: Given the largely observational evidence, objective testing and individualized treatment may be considered in high-risk patients, pending adequately powered trials. CPAP is the standard treatment for objectively confirmed OSA.
- Open Access
- 8 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1128
Human Factors and Device Engineering in OTC Intranasal Drug Delivery: GentleMist Technology™
Intranasal drug delivery is noninvasive, rapid-acting, and well suited to self-administration, yet the real-world performance of nasal sprays depends on the interaction among formulation, device mechanics, nasal anatomy, and user technique rather than on the active ingredient alone. This narrative review examines how aerosol science, regional targeting, and human factors jointly shape intranasal performance, using GentleMist Technology™ as a representative example of emerging device-centered development. Computational fluid dynamics (CFD) and anatomically informed in vitro models indicate that device geometry, plume characteristics, and administration angle can significantly alter where a dose is deposited, while human factors research identifies priming, positioning, and angulation as key determinants of successful over-the-counter (OTC) use. We summarize early feasibility data suggesting that angle-optimized administration may increase posterior nasopharyngeal delivery and that essential tasks are feasible for lay users, with priming emerging as a specific usability vulnerability. We also review preliminary clinical evidence on a chlorpheniramine maleate (CPM)-based intranasal formulation in allergic rhinitis and viral upper respiratory illness. Although the strongest device-specific findings remain preliminary and require independent replication, they support an emerging shift from a formulation-centered model toward an integrated device–formulation–user paradigm.
- 8 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1128
Open AccessHuman Factors and Device Engineering in OTC Intranasal Drug Delivery: GentleMist Technology™
Intranasal drug delivery is noninvasive, rapid-acting, and well suited to self-administration, yet the real-world performance of nasal sprays depends on the interaction among formulation, device mechanics, nasal anatomy, and user technique rather than on the active ingredient alone. This narrative review examines how aerosol science, regional targeting, and human factors jointly shape intranasal performance, using GentleMist Technology™ as a representative example of emerging device-centered development. Computational fluid dynamics (CFD) and anatomically informed in vitro models indicate that device geometry, plume characteristics, and administration angle can significantly alter where a dose is deposited, while human factors research identifies priming, positioning, and angulation as key determinants of successful over-the-counter (OTC) use. We summarize early feasibility data suggesting that angle-optimized administration may increase posterior nasopharyngeal delivery and that essential tasks are feasible for lay users, with priming emerging as a specific usability vulnerability. We also review preliminary clinical evidence on a chlorpheniramine maleate (CPM)-based intranasal formulation in allergic rhinitis and viral upper respiratory illness. Although the strongest device-specific findings remain preliminary and require independent replication, they support an emerging shift from a formulation-centered model toward an integrated device–formulation–user paradigm.
- Open Access
- 19 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 796
New Technique for Tramadol Dose Accuracy: Are Dosing Pumps the Solution?
Background/Objectives: Chronic pain represents a core global health burden and remains a leading cause of disability and reduced quality of life. Tramadol is a widely prescribed analgesic with a dual-opioid and non-opioid mechanism of action; however, safety concerns persist. This scoping review summarizes current evidence on tramadol pharmacology, dosing, and safety. Methods: A systematic literature search was conducted across main scientific databases to identify preclinical and clinical studies evaluating tramadol pharmacokinetics, safety, and dosing. Results: The same tramadol presentations have been used for several years, with a high overdose risk due to incorrect dosing measurements. Dosing pump devices represent a viable solution to improve dosing accuracy and minimize this risk. Conclusions: Tramadol drops seem like an easier administration pathway but require careful handling when taking the prescribed dose. A dosing pump in the medication bottle will improve dosing accuracy.
- 19 May 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 796
Open AccessNew Technique for Tramadol Dose Accuracy: Are Dosing Pumps the Solution?
Background/Objectives: Chronic pain represents a core global health burden and remains a leading cause of disability and reduced quality of life. Tramadol is a widely prescribed analgesic with a dual-opioid and non-opioid mechanism of action; however, safety concerns persist. This scoping review summarizes current evidence on tramadol pharmacology, dosing, and safety. Methods: A systematic literature search was conducted across main scientific databases to identify preclinical and clinical studies evaluating tramadol pharmacokinetics, safety, and dosing. Results: The same tramadol presentations have been used for several years, with a high overdose risk due to incorrect dosing measurements. Dosing pump devices represent a viable solution to improve dosing accuracy and minimize this risk. Conclusions: Tramadol drops seem like an easier administration pathway but require careful handling when taking the prescribed dose. A dosing pump in the medication bottle will improve dosing accuracy.
- Open Access
- 25 April 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 670
Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment
Background: H1-antihistamines are widely used for allergic and upper respiratory conditions; however, several agents included in this class have been associated with cardiac electrophysiological adverse effects, including QT interval prolongation and torsades de pointes (TdP). These effects are largely exposure-dependent and mechanistically linked to inhibition of cardiac ion channels. Chlorpheniramine maleate (CPM), a first-generation H1-antihistamine, has been implicated in arrhythmic events primarily under conditions of increased systemic exposure, prompting interest in whether alternative routes of administration may lower cardiac risk. Methods: This narrative review integrates mechanistic, preclinical, clinical, pharmacokinetic, and regulatory evidence. Information was extracted from PubMed, Google Scholar, and Scielo using search terms such as cardiotoxicity, chlorpheniramine, QT prolongation, intranasal administration, and cardiac arrhythmias, with no language restriction. Results: Comparative pharmacokinetic evidence shows that, on a dose-normalized basis, intranasal and oral chlorpheniramine exhibit comparable bioavailability; however, in a clinical context, intranasal doses (1.12–2.24 mg) are lower than oral daily doses (4–12 mg/day), resulting in a lower systemic exposure (Cmax and AUC) with intranasal administration. Available pharmacovigilance or epidemiological data have not specifically evaluated intranasal chlorpheniramine, and the number of dedicated safety trials remains limited. Conclusions: Preclinical, in vitro, mechanistic studies suggest that intranasal administration of chlorpheniramine should confer superior cardiac safety compared to the oral route. However, clinical data from human studies directly comparing the cardiac safety of intranasal chlorpheniramine versus systemic chlorpheniramine is extremely limited. More data from clinical trials, case–control studies, and regulatory databases are needed to validate these theoretical claims.
- 25 April 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (5) , 670
Open AccessCardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment
Background: H1-antihistamines are widely used for allergic and upper respiratory conditions; however, several agents included in this class have been associated with cardiac electrophysiological adverse effects, including QT interval prolongation and torsades de pointes (TdP). These effects are largely exposure-dependent and mechanistically linked to inhibition of cardiac ion channels. Chlorpheniramine maleate (CPM), a first-generation H1-antihistamine, has been implicated in arrhythmic events primarily under conditions of increased systemic exposure, prompting interest in whether alternative routes of administration may lower cardiac risk. Methods: This narrative review integrates mechanistic, preclinical, clinical, pharmacokinetic, and regulatory evidence. Information was extracted from PubMed, Google Scholar, and Scielo using search terms such as cardiotoxicity, chlorpheniramine, QT prolongation, intranasal administration, and cardiac arrhythmias, with no language restriction. Results: Comparative pharmacokinetic evidence shows that, on a dose-normalized basis, intranasal and oral chlorpheniramine exhibit comparable bioavailability; however, in a clinical context, intranasal doses (1.12–2.24 mg) are lower than oral daily doses (4–12 mg/day), resulting in a lower systemic exposure (Cmax and AUC) with intranasal administration. Available pharmacovigilance or epidemiological data have not specifically evaluated intranasal chlorpheniramine, and the number of dedicated safety trials remains limited. Conclusions: Preclinical, in vitro, mechanistic studies suggest that intranasal administration of chlorpheniramine should confer superior cardiac safety compared to the oral route. However, clinical data from human studies directly comparing the cardiac safety of intranasal chlorpheniramine versus systemic chlorpheniramine is extremely limited. More data from clinical trials, case–control studies, and regulatory databases are needed to validate these theoretical claims.
- Open Access
- 1 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (4) , e2500283
Women Going Forward in Survival (Mujeres Avanzando a la Sobrevida): A Prospective Breast Cancer Cohort Study in Honduras
PURPOSE: Breast cancer mortality rates are disproportionately high in low- and middle-income countries. The primary reasons for high mortality rates are delays to diagnosis and treatment leading to late-stage presentation. Mujeres Avanzando a la Sobrevida is a prospective cohort study of two cancer centers in Honduras which aimed to map the current landscape of breast cancer in Honduras and understand delays in diagnosis and treatment. METHODS: All women older than 18 years with newly diagnosed invasive breast cancer were included. Demographic, cancer, and treatment data were collected at pertinent time intervals for diagnosis and treatment. The Unger Saldaña Delay Survey was used to evaluate patients' perceptions of and reasons for delays in cancer care. RESULTS: A total of 184 patients with a median age of 53 years at diagnosis were enrolled; 85.0% had T2-T3 tumors. Sixty percent had stage III or IV cancer, and 70% had axillary node involvement. The mean time interval from the first symptom to the initial treatment was 386 days; from the first symptom to the first provider visit (patient interval) was 205 days; from first provider to biopsy (diagnostic interval) was 79 days; and from biopsy to initial treatment (treatment interval) was 98 days. Despite these delays, 74% of patients felt they sought care promptly. The most cited self-reported reason for these delays was patients' belief in self-improvement. CONCLUSION: Honduras faces significant delays in three critical intervals of breast cancer diagnosis and treatment. Targeted interventions are needed to enhance cancer awareness and health promotion among the population, provide specific cancer care training for clinicians, and design and implement straightforward navigation pathways for timely referrals.
- 1 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (4) , e2500283
Open AccessWomen Going Forward in Survival (Mujeres Avanzando a la Sobrevida): A Prospective Breast Cancer Cohort Study in Honduras
PURPOSE: Breast cancer mortality rates are disproportionately high in low- and middle-income countries. The primary reasons for high mortality rates are delays to diagnosis and treatment leading to late-stage presentation. Mujeres Avanzando a la Sobrevida is a prospective cohort study of two cancer centers in Honduras which aimed to map the current landscape of breast cancer in Honduras and understand delays in diagnosis and treatment. METHODS: All women older than 18 years with newly diagnosed invasive breast cancer were included. Demographic, cancer, and treatment data were collected at pertinent time intervals for diagnosis and treatment. The Unger Saldaña Delay Survey was used to evaluate patients' perceptions of and reasons for delays in cancer care. RESULTS: A total of 184 patients with a median age of 53 years at diagnosis were enrolled; 85.0% had T2-T3 tumors. Sixty percent had stage III or IV cancer, and 70% had axillary node involvement. The mean time interval from the first symptom to the initial treatment was 386 days; from the first symptom to the first provider visit (patient interval) was 205 days; from first provider to biopsy (diagnostic interval) was 79 days; and from biopsy to initial treatment (treatment interval) was 98 days. Despite these delays, 74% of patients felt they sought care promptly. The most cited self-reported reason for these delays was patients' belief in self-improvement. CONCLUSION: Honduras faces significant delays in three critical intervals of breast cancer diagnosis and treatment. Targeted interventions are needed to enhance cancer awareness and health promotion among the population, provide specific cancer care training for clinicians, and design and implement straightforward navigation pathways for timely referrals.
- Open Access
- 6 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Congenital Knee Dislocation: A Case Report
Congenital knee dislocation (CKD) is a rare anomaly characterized by anterior and lateral displacement of the tibia in relation to the femur. Its incidence is 0.017 per 1000 live births, predominating in the female sex. Its etiology is unknown, but intrinsic (genetic) and extrinsic (mechanical) predisposing factors have been identified. Treatment ranges from conservative measures to surgery, depending on the severity of the case. This study aims to present a case of CKD not associated with other pathologies and highlight its favorable progression through timely diagnosis and conservative management. We present a full‐term newborn with a diagnosis of left CKD. Physical examination revealed genu recurvatum in reducible hyperextension. The x‐ray confirmed grade III dislocation. Manual reduction was performed with immobilization by means of a thigh splint, with improvement after 7 days. At 5 months, the patient presented satisfactory evolution without functional limitations. CKD has three severity grades and various causes. Diagnosis is made clinically and radiographically, and sometimes prenatally. Grades I–II are treated conservatively; grade III or non‐improving cases may require surgery. Early detection improves prognosis.
- 6 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Open AccessCongenital Knee Dislocation: A Case Report
Congenital knee dislocation (CKD) is a rare anomaly characterized by anterior and lateral displacement of the tibia in relation to the femur. Its incidence is 0.017 per 1000 live births, predominating in the female sex. Its etiology is unknown, but intrinsic (genetic) and extrinsic (mechanical) predisposing factors have been identified. Treatment ranges from conservative measures to surgery, depending on the severity of the case. This study aims to present a case of CKD not associated with other pathologies and highlight its favorable progression through timely diagnosis and conservative management. We present a full‐term newborn with a diagnosis of left CKD. Physical examination revealed genu recurvatum in reducible hyperextension. The x‐ray confirmed grade III dislocation. Manual reduction was performed with immobilization by means of a thigh splint, with improvement after 7 days. At 5 months, the patient presented satisfactory evolution without functional limitations. CKD has three severity grades and various causes. Diagnosis is made clinically and radiographically, and sometimes prenatally. Grades I–II are treated conservatively; grade III or non‐improving cases may require surgery. Early detection improves prognosis.
- Open Access
- 5 February 2026
- Published by Universidad Católica de Honduras in Salus et Vita
- Vol. 1 (2) , 38-41
Carcinoma de células de Merkel en extremidad inferior: reporte de un caso y revisión breve de la literatura
Introducción: El carcinoma de células de Merkel es un cáncer neuroendocrino poco frecuente que se localiza en áreas fotoexpuestas de la piel. Afecta con frecuencia a personas mayores de 50 años, y se presenta con pápulas o nódulos firmes, asintomáticos y de rápido crecimiento, lo que empeora su pronóstico. Se sugiere realizar una exploración física, biopsia de piel y de ganglios linfáticos centinelas para determinar un diagnóstico oportuno. Posteriormente, se recomienda aplicar una prueba de serología de poliomavirus de Merkel. Se describe el caso de una paciente en buen estado general con un carcinoma de células de Merkel cuyas manifestaciones son compatibles con las características clínicas de carcinoma asociado al poliomavirus de Merkel. El objetivo de este caso es reportar las características clínicas, diagnóstico y evolución del carcinoma de células de Merkel, una neoplasia poco frecuente reportada.
- 5 February 2026
- Published by Universidad Católica de Honduras in Salus et Vita
- Vol. 1 (2) , 38-41
Open AccessCarcinoma de células de Merkel en extremidad inferior: reporte de un caso y revisión breve de la literatura
Introducción: El carcinoma de células de Merkel es un cáncer neuroendocrino poco frecuente que se localiza en áreas fotoexpuestas de la piel. Afecta con frecuencia a personas mayores de 50 años, y se presenta con pápulas o nódulos firmes, asintomáticos y de rápido crecimiento, lo que empeora su pronóstico. Se sugiere realizar una exploración física, biopsia de piel y de ganglios linfáticos centinelas para determinar un diagnóstico oportuno. Posteriormente, se recomienda aplicar una prueba de serología de poliomavirus de Merkel. Se describe el caso de una paciente en buen estado general con un carcinoma de células de Merkel cuyas manifestaciones son compatibles con las características clínicas de carcinoma asociado al poliomavirus de Merkel. El objetivo de este caso es reportar las características clínicas, diagnóstico y evolución del carcinoma de células de Merkel, una neoplasia poco frecuente reportada.
- Open Access
- 3 October 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Reports
- Vol. 86 (04) , e225-e229
Low-cost Posterior C1–C2 Fusion Using Sublaminar Wiring in Neurologically Intact Young Patient with Type IIA Odontoid Fracture: A Resource-oriented Approach
To present a low-cost posterior cervical fixation technique using sublaminar wiring for the management of a comminuted odontoid fracture (type IIA) in a young, neurologically intact patient, emphasizing its relevance in low-resource environments where advanced instrumentation is inaccessible. A 21-year-old male sustained a comminuted fracture of the odontoid process of C2 following a high-impact motorcycle accident. Upon admission, he was alert, fully oriented, and neurologically intact. Imaging revealed a comminuted type IIA odontoid fracture without displacement. Due to the patient's economic limitations and the unsuitability of the fracture for anterior fixation, a posterior approach using double sublaminar wiring between C1 and C2 with autologous iliac crest bone graft was performed. The procedure was successfully completed with no intraoperative or postoperative complications. The patient was discharged on postoperative day 2 and demonstrated excellent recovery. Follow-up imaging at 3 months confirmed over 90% fracture consolidation. Imaging at 6 months was requested but not obtained due to loss of follow-up. Functional recovery was complete, with only a partial reduction in cervical range of motion as expected with C1–C2 fusion. Sublaminar wiring offers a safe, effective, and affordable alternative for posterior fixation of comminuted odontoid fractures, particularly in young patients and in settings where access to advanced spinal instrumentation is limited.
- 3 October 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Reports
- Vol. 86 (04) , e225-e229
Open AccessLow-cost Posterior C1–C2 Fusion Using Sublaminar Wiring in Neurologically Intact Young Patient with Type IIA Odontoid Fracture: A Resource-oriented Approach
To present a low-cost posterior cervical fixation technique using sublaminar wiring for the management of a comminuted odontoid fracture (type IIA) in a young, neurologically intact patient, emphasizing its relevance in low-resource environments where advanced instrumentation is inaccessible. A 21-year-old male sustained a comminuted fracture of the odontoid process of C2 following a high-impact motorcycle accident. Upon admission, he was alert, fully oriented, and neurologically intact. Imaging revealed a comminuted type IIA odontoid fracture without displacement. Due to the patient's economic limitations and the unsuitability of the fracture for anterior fixation, a posterior approach using double sublaminar wiring between C1 and C2 with autologous iliac crest bone graft was performed. The procedure was successfully completed with no intraoperative or postoperative complications. The patient was discharged on postoperative day 2 and demonstrated excellent recovery. Follow-up imaging at 3 months confirmed over 90% fracture consolidation. Imaging at 6 months was requested but not obtained due to loss of follow-up. Functional recovery was complete, with only a partial reduction in cervical range of motion as expected with C1–C2 fusion. Sublaminar wiring offers a safe, effective, and affordable alternative for posterior fixation of comminuted odontoid fractures, particularly in young patients and in settings where access to advanced spinal instrumentation is limited.
- Open Access
- 1 October 2025
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 20 (Vol. 20 (2) , 1050
Implementing oxygen saturation-based criteria for discontinuation of long-term oxygen therapy in nursing home residents with chronic respiratory disease
Background: Chronic respiratory diseases represent a significant global health burden, affecting millions of individuals. Long-term oxygen therapy (LTOT) has been a key treatment for patients with chronic hypoxemia due to these conditions, demonstrating benefits for survival and quality of life. Methods: An observational, analytical, retrospective cohort study was conducted to evaluate clinical indicators for safely discontinuing oxygen therapy in 36 patients aged 50 years or older with chronic respiratory diseases residing in five nursing homes. Data included sociodemographic and clinical variables, such as comorbidities, oxygen saturation levels, and treatment details. A cohort of 36 nursing home residents with chronic respiratory diseases was analyzed. Results: The study revealed that 83.3% of patients had at least one comorbidity. Most patients (80.6%) used a nasal cannula for oxygen delivery, with a mean flow rate of 2.06 L/min. Approximately 80.6% achieved oxygen saturation >92% without supplemental oxygen. None of the patients who discontinued oxygen required readmission or oxygen reinstatement within the 4-week follow-up period. Conclusions: This study provides preliminary evidence that achieving oxygen saturation >92% at rest or in exertion may represent a potential clinical indicator for safely discontinuing supplemental oxygen in patients with chronic respiratory diseases. However, given the retrospective design and small sample size, these findings should be interpreted cautiously and validated in larger, prospective studies.
- 1 October 2025
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 20 (Vol. 20 (2) , 1050
Open AccessImplementing oxygen saturation-based criteria for discontinuation of long-term oxygen therapy in nursing home residents with chronic respiratory disease
Background: Chronic respiratory diseases represent a significant global health burden, affecting millions of individuals. Long-term oxygen therapy (LTOT) has been a key treatment for patients with chronic hypoxemia due to these conditions, demonstrating benefits for survival and quality of life. Methods: An observational, analytical, retrospective cohort study was conducted to evaluate clinical indicators for safely discontinuing oxygen therapy in 36 patients aged 50 years or older with chronic respiratory diseases residing in five nursing homes. Data included sociodemographic and clinical variables, such as comorbidities, oxygen saturation levels, and treatment details. A cohort of 36 nursing home residents with chronic respiratory diseases was analyzed. Results: The study revealed that 83.3% of patients had at least one comorbidity. Most patients (80.6%) used a nasal cannula for oxygen delivery, with a mean flow rate of 2.06 L/min. Approximately 80.6% achieved oxygen saturation >92% without supplemental oxygen. None of the patients who discontinued oxygen required readmission or oxygen reinstatement within the 4-week follow-up period. Conclusions: This study provides preliminary evidence that achieving oxygen saturation >92% at rest or in exertion may represent a potential clinical indicator for safely discontinuing supplemental oxygen in patients with chronic respiratory diseases. However, given the retrospective design and small sample size, these findings should be interpreted cautiously and validated in larger, prospective studies.
- Open Access
- 17 March 2024
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 18 (1) , 1-6
Giant stone adhered in the vaginal cavity in a female patient with type 2 diabetes mellitus: a case report
Background: Bladder lithiasis comprises 5% of urological lithiasis. Large bladder stones associated with vesicovaginal fistulas are rare, and the risk factors are not an isolated process. There are metabolic comorbidities associated with this pathology, including diabetes mellitus. Case presentation: A 70-year-old Mestizo patient is presented, reporting dysuria, pollakiuria, and abdominal pain of 4 months of evolution, located in the hypogastric region, also with a sensation of a foreign body in the vaginal introitus. In her pathological history, she presented type 2 diabetes mellitus. A computed tomography scan of the abdomen and pelvis was performed, reporting a tumor lesion in the abdominal wall. Therefore, surgical intervention was performed by cystolithotomy, obtaining a giant stone adhered to the vaginal wall with a size of 10 cm × 12 cm. Conclusion: Early detection of this pathology should be exhaustive in patients with characteristics and comorbidities associated with stone development to avoid possible complications, such as vesicovaginal fistulas.
- 17 March 2024
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 18 (1) , 1-6
Open AccessGiant stone adhered in the vaginal cavity in a female patient with type 2 diabetes mellitus: a case report
Background: Bladder lithiasis comprises 5% of urological lithiasis. Large bladder stones associated with vesicovaginal fistulas are rare, and the risk factors are not an isolated process. There are metabolic comorbidities associated with this pathology, including diabetes mellitus. Case presentation: A 70-year-old Mestizo patient is presented, reporting dysuria, pollakiuria, and abdominal pain of 4 months of evolution, located in the hypogastric region, also with a sensation of a foreign body in the vaginal introitus. In her pathological history, she presented type 2 diabetes mellitus. A computed tomography scan of the abdomen and pelvis was performed, reporting a tumor lesion in the abdominal wall. Therefore, surgical intervention was performed by cystolithotomy, obtaining a giant stone adhered to the vaginal wall with a size of 10 cm × 12 cm. Conclusion: Early detection of this pathology should be exhaustive in patients with characteristics and comorbidities associated with stone development to avoid possible complications, such as vesicovaginal fistulas.